Effects of Buspar on Depressive Symptom Improvement and Neuroprotection in Patients With Anxiety Disorder

NCT01546896 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Anxiety Disorder

Interventions

DRUG: buspirone+alprazolam
DRUG: alprazolam

Sponsor

Seoul National University Hospital